Andere Sprachen COSMOS Pharmaceutical Corporation

Aktien

A0DLJE

JP3298400007

3349

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 24.04.2024			% 5 Tage	% 1. Jan.
14.415 ^JPY	-0,35 %		+3,30 %	-11,48 %

12.04.	Cosmos Pharmaceutical's zurechenbarer Gewinn steigt um 6,6% in den ersten neun Monaten des Geschäftsjahres	MT
12.04.	COSMOS Pharmaceutical Corporation gibt Dividendenprognose für das Geschäftsjahr bis zum 31. Mai 2024 ab	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	12.04.
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	12.04.
Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores	12.01.
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	12.01.
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024	12.01.
Criptomonedas: Tres temáticas a tener en cuenta	21.12.
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores	12.10.23
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023	11.10.23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	11.10.23
OPINIONES DE LOS ANALISTAS DEL DÍA : Santander, Demant, Lufthansa, AXA, BAE Systems, Adidas, GSK, Demant, Just Eat...	08.08.23
Revenez, la semaine n'est pas finie !	08.08.23
AVIS D'ANALYSTES DU JOUR : Saint-Gobain, AXA, Crédit Agricole, Adidas, Demant, Ipsen, Just Eat...	08.08.23
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023	11.07.23
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024	10.07.23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	10.07.23
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings	11.04.23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	10.04.23
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023	10.04.23
AVIS D'ANALYSTES DU JOUR : Airbus, Thales, STMicroelectronics, FDJ, Ubisoft, TF1, Ferrari, Cosmo...	31.01.23
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy	16.01.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen COSMOS Pharmaceutical Corporation

Aktien

A0DLJE

JP3298400007

3349

Andere Sprachen

Filter